This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): SENS401, SENS 401
Description: SENS-401 is a new drug candidate for treating vestibular and auditory disorders resulting from lesions of the inner ear.This drug is an enantiomer of SENS-218. SENS-401 is a small molecule that can be taken orally or via an injection.
Additional information available to subscribers only: